Dahlen tapped as NeuroSearch CEO

NeuroSearch has named Patrik Dahlen as the new CEO of the company, replacing Flemming Pedersen, who has resigned to take up a new position in another company. NeuroSearch release

Torbjorn Bjerke has been appointed as new CEO for Karolinska Development. He is currently CEO for Orexo, a position he has held since 2007. Karolinska Development release

Caris Life Sciences has announced that Winston K.C. Lam has joined the company as executive VP, business development and chief legal officer. Claris release

Jennerex has appointed Lara Longpre to the position of COO. Jennerex release

Discovery Laboratories has realigned the company's executive management by appointing Thomas Miller as COO, Charles Katzer as chief technical officer and John Cooper as president and CFO. Discovery Labs release

Regenicin has announced Joseph Rubinfeld, one of the four original founders of Amgen, has agreed to join the company's board of directors. Regenicin release

Suggested Articles

Preclinical-stage biotech Abpro Therapeutics wants to trial its two lead candidates for HER2-positive cancers and diabetic macular edema in 2019.

After a rough patch in 2017, the stars seem to be realigning for French CAR-T expert Cellectis, which just closed a $164 million U.S. public offering.

Investment firm Frazier Healthcare Partners has closed its 11th fund—worth $780 million—that will help established companies accelerate their growth.